Commercializing In-Home Supportive Technolgy for Dementia Caregivers
将痴呆症护理人员的家庭支持技术商业化
基本信息
- 批准号:10493426
- 负责人:
- 金额:$ 164.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAdverse effectsAlgorithmsAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnxietyApple watchApplied ResearchAwardBasic ScienceBehaviorBehavioral SymptomsCaliforniaCaregiver supportCaregiversCaringCause of DeathChineseCloud ServiceCognitiveDataDementiaDementia caregiversDetectionDevicesDiseaseDisease ProgressionEmergency SituationEmotionalEventFamilyFamily CaregiverFoundationsFriendsFundingFutureHealthHomeHome environmentHourIndividualIndustryIntellectual PropertyInternetInternet of ThingsInterventionLaboratoriesLanguageLearningLegal patentLifeLocationMarketingMental DepressionMental HealthMonitorMotorMovementPathway interactionsPatternPersonal SatisfactionPersonsPhasePsychophysiologyQuality of CareRandomized Controlled TrialsReadinessReportingResearchResourcesRiskRunningRuralSafetySelf-Help DevicesServicesSmall Business Innovation Research GrantSocial isolationStressSystemTechnologyTimeTraining SupportTrustUnderserved PopulationUniversitiesWorkbasecare giving burdencaregiver stresscaregivingcommercializationcommunity settingeffective therapyemotional functioningfallsimprovedinterestloved onesmachine learning algorithmmild cognitive impairmentmonitoring devicemortalityphysical conditioningprogramspsychoeducationresearch and developmentrural areasatisfactionsensorskills trainingtelephone sessionwearable device
项目摘要
Abstract
Caring for a loved one with Alzheimer’s disease, related dementias, or mild cognitive impairment is a highly
meaningful part of family life. However, the associated burden and strain can have adverse effects on
caregivers including declines in mental and physical health, reduced well-being, and increased mortality.
These effects can compromise care quality for people with dementia (PWD). Empirically-supported
interventions are needed that: (a) target mechanisms and pathways shown to connect troublesome behavioral
symptoms in PWD with adverse effects in caregivers; (b) make low demands on caregivers’ limited time and
energy; (c) can be personalized and adapted to the needs of different caregivers and PWDs as they change
over time; and (d) can be disseminated successfully into larger community settings. In this Commercialization
Readiness Pilot (CRP) application, we seek support for technical assistance and late stage research and
development activities prior to the commercial launch of People Power Caregiver (PPCg). PPCg consists of a
hardware system (sensors, monitoring devices, wearables), apps, and cloud services that combine Internet-of-
Things (i.e., devices that communicate automatically over the internet) technologies with machine learning
algorithms that run in the home and in the cloud to create a more supportive home environment for caregivers
and people in their care. PPCg was developed with support from an SBIR Fast Track award to People Power
Company and the Berkeley Psychophysiology Laboratory (BPL) at the University of California, Berkeley.
People Power is an award-winning, established leader in home monitoring and Internet-of-Things technology.
BPL has been engaged in basic and applied research with PWDs and their caregivers for almost 20 years.
CRP funding would enable us to commercialize PPCg successfully by supporting three specific aims:
Aim 1: Increase PPCg accessibility. We will develop new versions of PPCg and conduct randomized
controlled trials (RCTs) in underserved populations that evaluate effects on caregiver health, well-being, and
user satisfaction in rural homes (Study 1) and Spanish language homes (Study 2).
Aim 2: Increase PPCg support for wearable devices. We will evaluate PPCg with two wearable devices that
monitor PWD movement and location, analyzing CareActive watch data (Study 3) as a way of improving
alerting of worrisome events (e.g., wandering), and conducting an RCT with Apple watches (Study 4) to
determine effects on caregiver health, well-being, and user satisfaction.
Aim 3: Readying People Power for commercializing PPCg. To prepare People Power to commercialize
PPCg successfully, we will: (a) add Spanish-speaking customer service staff; (b) increase intellectual property
protection by filing 5 non-provisional PPCg patent applications; and (c) partner with companies that serve large
numbers of older customers (e.g., telecom companies and utilities) and have deep senior care expertise (e.g.,
professional caregiver agencies) to market and distribute PPCg.
抽象的
照顾患有阿尔茨海默病、相关痴呆症或轻度认知障碍的亲人是一项高度艰巨的任务
家庭生活中有意义的一部分。然而,相关的负担和压力可能会对
照顾者的健康状况下降,包括身心健康下降、幸福感下降和死亡率上升。
这些影响可能会影响痴呆症患者 (PWD) 的护理质量。经验支持
需要采取以下干预措施:(a) 旨在将麻烦的行为联系起来的目标机制和途径
残疾人士症状对护理人员产生不利影响; (b) 对照顾者有限的时间要求较低
活力; (c) 可以个性化并适应不同护理人员和残疾人的变化需求
随着时间的推移; (d) 可以成功地传播到更大的社区环境中。在这次商业化中
准备试点(CRP)申请,我们寻求技术援助和后期研究的支持
People Power Caregiver (PPCg) 商业发布之前的开发活动。 PPCg 由
结合物联网的硬件系统(传感器、监控设备、可穿戴设备)、应用程序和云服务
具有机器学习功能的物(即通过互联网自动通信的设备)技术
在家庭和云端运行的算法,为护理人员创造更具支持性的家庭环境
以及他们照顾的人。 PPCg 的开发得到了 SBIR Fast Track 奖 People Power 的支持
公司和加州大学伯克利分校的伯克利心理生理学实验室 (BPL)。
People Power 是家庭监控和物联网技术领域屡获殊荣的知名领导者。
BPL 近 20 年来一直致力于残疾人及其护理人员的基础和应用研究。
CRP 资金将使我们能够通过支持三个具体目标成功地将 PPCg 商业化:
目标 1:提高 PPCg 的可访问性。我们将开发新版本的PPCg并进行随机
在服务不足的人群中进行对照试验(RCT),评估对护理人员健康、福祉和健康的影响
农村家庭(研究 1)和西班牙语家庭(研究 2)的用户满意度。
目标 2:增加 PPCg 对可穿戴设备的支持。我们将使用两款可穿戴设备来评估 PPCg
监测残疾人的运动和位置,分析 CareActive 手表数据(研究 3)作为改进的一种方式
提醒令人担忧的事件(例如,徘徊),并使用 Apple Watch 进行随机对照试验(研究 4)
确定对护理人员健康、福祉和用户满意度的影响。
目标 3:为 PPCg 商业化做好准备。准备人民力量商业化
PPCg 成功后,我们将: (a) 增加讲西班牙语的客户服务人员; (b) 增加知识产权
通过提交 5 项非临时 PPCg 专利申请来获得保护; (c) 与为大型企业提供服务的公司合作
大量老年客户(例如电信公司和公用事业公司)并且拥有深厚的老年护理专业知识(例如
专业护理机构)营销和分销 PPCg。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gene Wang其他文献
Gene Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gene Wang', 18)}}的其他基金
Commercializing In-Home Supportive Technolgy for Dementia Caregivers
将痴呆症护理人员的家庭支持技术商业化
- 批准号:
10259751 - 财政年份:2021
- 资助金额:
$ 164.66万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 164.66万 - 项目类别:
Research Grant














{{item.name}}会员




